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A 71-year-old man who was a carrier of the hepatitis C virus
developed megalocytic anemia. Repeated bone marrow biopsy
samples indicated myelodysplastic syndrome (MDS) and the pa-
tient subsequently developed myeloﬁbrosis within 6 months. As a
result, the patient received regular blood transfusions approxi-
mately every 2 weeks. However, thrombocytopenia occurred 1
year later and the peripheral blood examination revealed intermit-
tent blast formation.
The patient was then admitted to our hospital with bacterial
sinusitis and a low leukocyte count (1400/mL). Multiple asymptom-
atic small scattered erythematous or skin-colored papules were
found over both hands and the palms, forearms, and lower legs of
the patient on admission (Figure 1). A dermatologist was consulted
and a skin biopsy sample was taken. Pathological analysis showed
several stellate-shaped palisaded granulomas with central necro-
biosis in the reticular dermis, accompanied by moderate perivascu-
lar and interstitial inﬁltration of lymphocytes, histiocytes, and some
neutrophils in the adjacent dermis (Figure 2). No signiﬁcant nuclear
atypia in the inﬂammatory cells was noted. There was no caseous-
type necrosis, and periodic acideSchiff staining was negative for
fungi. The cluster of differentiation-68 immunohistochemical
staining showed an increase in the number of histiocytes and their
palisade arrangement and interstitial granulomatous inﬁltration,
consistent with granuloma annulare (GA). Desoximetasone 0.25%
cream was prescribed twice daily to control his skin rash after
discharge. Unfortunately, the patient returned 2 weeks later with
a very high blast count (47%), as indicated by a peripheral blood
test. He was diagnosed with acute myeloid leukemia (AML) trans-
formation, and chemotherapy with a low dose of cytarabine was
started. The patient did not respond well to treatment and his con-
dition rapidly worsened. Supportive palliative care was given after
thorough discussion with him and his family. He died 3 months af-
ter the diagnosis of AML.
Associations between GA and several types of systemic disease
have been reported previously, including diabetes mellitus, thyroid
disease, dyslipidemia, and immunocompromised status.1 Similarly,
the occurrence of eruptive GA and subsequent or concurrent malig-
nancies such as lymphoma, leukemia, and solid cancers have also
been documented.2 Our patient developed an acute onset of gener-
alized eruptive GA weeks before acute leukemic transformation ofConﬂicts of interest: The authors have no conﬂicts of interest relevant to this article.
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the occurrence of eruptive GA may be an indicator of acute
leukemic change in patients with MDS.
Some recent studies have shown that cutaneous eruptions in
patients with MDS may herald a transition to AML and are asso-
ciated with a poorer prognosis. The speciﬁc cutaneous manifesta-
tion of MDS is the dermal inﬁltration of malignant hematopoietic
cells, which is rare, but highly indicative of acute leukemic trans-
formation.3 An association between GA and hematogenous ma-
lignancy has been previously described in a child with MDS; in
this patient the skin lesions initially cleared spontaneously, but
recurred when the acute leukemic transformation exacerbated.4
Another case report described a patient with MDS who devel-
oped disseminated cutaneous granulomatous eruptions before
progression to AML. The skin lesions subsided after his AML
was controlled by chemotherapy.5 Our patient had similar clin-
ical manifestations, with eruptive GA appearing just weeks
before AML transformation. However, more observations are
needed to clarify the pathogenesis of this phenomenon and to
determine whether GA and AML are simply coincidental events
or whether the acute onset of generalized eruptive GA can be
regarded as a paraneoplastic phenomenon.
While researching the possible causes of GA in our patient, we
came across three case reports mentioning GA in carriers of the
hepatitis C virus. However, two of these were associated with the
use of pegylated interferon-alpha.6,7 Our patient did not receive
treatment with interferon and liver function tests indicated no
impairment during admission. Thus we believe that it is less likely
that the occurrence of GA eruptions was related to the hepatitis C
virus infection rather than the AML.
Currently, the gold standard treatment for GA is debatable.
However, when strong associations exist between GA and an un-
derlying systemic disease, patients may beneﬁt from therapeutic
strategies aimed at the underlying disease, such as aggressive
chemotherapy and allogeneic bone marrow transplantation.3 How-
ever, the evidence from previously published work could not be
directly applied to our patient.
In conclusion, we observed that MDS progressed rapidly into
acute leukemia after the development of eruptive GA. Although
the phenomenon may represent a coincidental occurrence, these
patients should be followed up carefully for the possibility of the
presence of an associated systemic disease.ier Taiwan LLC. All rights reserved.
Figure 1 Clinical features. Multiple scattered erythematous or skin-colored papules are seen over the bilateral forearms, dorsal hands, and palms.
Figure 2 Histopathological ﬁndings of palisaded granulomas with central necrobiosis
in the reticular dermis.
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